Advanced search
Publication Cover
Acta Oncologica Volume 61, 2022 - Issue 5
Journal homepage
1,143
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor: Clinical Oncology

Etoposide-containing regimens for the treatment of critically ill patients with hematological malignancy-related hemophagocytic lymphohistiocytosis

Clara Vignerona Service de Médecine Intensive-Réanimation, Hôpital Cochin, AP-HP. Centre, Paris, France;b Université de Paris, Paris, FranceORCID Iconhttps://orcid.org/0000-0002-6966-5268
ORCID Icon,
Valentine Le Stanga Service de Médecine Intensive-Réanimation, Hôpital Cochin, AP-HP. Centre, Paris, France
,
Justine Decroocqb Université de Paris, Paris, France;c Service d’Hématologie, Hôpital Cochin, AP-HP. Centre, Paris, France
,
Edwige Péjua Service de Médecine Intensive-Réanimation, Hôpital Cochin, AP-HP. Centre, Paris, France;b Université de Paris, Paris, France;d Institut Cochin, INSERM U1016, CNRS UMR8104, Paris, FranceORCID Iconhttps://orcid.org/0000-0001-7356-7858
ORCID Icon,
Barbara Burronie Service d’Anatomie Pathologique, Hôpital Cochin, AP-HP. Centre, Paris, France;f Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université de Paris, Paris, France
,
Nicolas Chapuisb Université de Paris, Paris, France;d Institut Cochin, INSERM U1016, CNRS UMR8104, Paris, France;g Service d’Hématologie Biologique, Hôpital Cochin, AP-HP. Centre, Paris, FranceORCID Iconhttps://orcid.org/0000-0003-0601-3948
ORCID Icon,
Julien Charpentiera Service de Médecine Intensive-Réanimation, Hôpital Cochin, AP-HP. Centre, Paris, FranceORCID Iconhttps://orcid.org/0000-0003-3117-1235
ORCID Icon &
Frédéric Pènea Service de Médecine Intensive-Réanimation, Hôpital Cochin, AP-HP. Centre, Paris, France;b Université de Paris, Paris, France;d Institut Cochin, INSERM U1016, CNRS UMR8104, Paris, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3639-3849
ORCID Icon show all
Pages 608-610 | Received 10 Jan 2022, Accepted 14 Feb 2022, Published online: 04 Mar 2022

References

  • Buyse S, Teixeira L, Galicier L, et al. Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med. 2010;36(10):1695–1702.
  • Valade S, Monseau G, Mariotte E, et al. Diagnostic performance of hemophagocytic lymphohistiocytosis criteria and HScore in critically ill patients with severe hemophagocytic syndrome. Crit Care Med. 2021;49:e874–e879.
  • Ramos-Casals M, Brito-Zerón P, López-Guillermo A, et al. Adult haemophagocytic syndrome. Lancet. 2014;383(9927):1503–1516.
  • Setiadi A, Zoref-Lorenz A, Lee CY, et al. Malignancy-associated haemophagocytic lymphohistiocytosis. Lancet Haematol. 2022;S2352302621003665.
  • La Rosée P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465–2477.
  • Arca M, Fardet L, Galicier L, et al. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide. Br J Haematol. 2015;168(1):63–68.
  • Knaak C, Schuster FS, Nyvlt P, et al. Treatment and mortality of hemophagocytic lymphohistiocytosis in adult critically ill patients: a systematic review with pooled analysis. Crit Care Med. 2020;48(11):e1137–e1146.
  • Song Y, Wang J, Wang Y, et al. Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis. Cancer Biol Ther. 2021;22(10–12):598–606.
  • Cherruault M, Le Goff M, Tamburini J, et al. Urgent chemotherapy in Sepsis-Like shock related to hematologic malignancies. Crit Care Med. 2018;46(5):e465–e468.
  • Lecuyer L, Chevret S, Thiery G, et al. The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med. 2007;35:808–814.
  • Hande KR. Etoposide: four decades of development of a topoisomerase II inhibitor. Eur J Cancer. 1998;34(10):1514–1521.
  • Johnson TS, Terrell CE, Millen SH, et al. Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis. J Immunol. 2014;192(1):84–91.
  • Dufranc E, Del Bello A, Belliere J, et al. IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome. Crit Care. 2020;24(1):166.
  • Wohlfarth P, Agis H, Gualdoni GA, et al. Interleukin 1 receptor antagonist anakinra, intravenous immunoglobulin, and corticosteroids in the management of critically ill adult patients with hemophagocytic lymphohistiocytosis. J Intensive Care Med. 2019;34(9):723–731.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.